By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Regenacy Pharma 



Boston  Massachusetts    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Regenacy Pharmaceuticals, LLC focuses on the development of novel drug candidates that selectively regenerate intracellular transport and upregulate gene expression to modify the course of disease.

LEADERSHIP:

CEO: Walter C. Ogier



Key Statistics


Email:
Ownership: Private

Web Site: Regenacy Pharma
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
Regenacy Pharma Presents Data Demonstrating That HDAC1,2 Inhibition Improved Cognitive Function In Mouse Models Of Alzheimer's Disease At The Alzheimer’s Association International Conference 7/20/2017 11:07:17 AM
Regenacy Pharma Presents Data Demonstrating That HDAC1,2 Inhibition Improved Cognitive Function In Mouse Models Of Alzheimer's Disease At The Alzheimer’s Association International Conference 7/19/2017 10:42:06 AM
Regenacy Pharma Appoints Simon S. Jones As President And Chief Executive Officer 6/27/2017 6:43:15 AM
Regenacy Pharma Demonstrates Reversal Of Chemotherapy-Induced Peripheral Neuropathy With HDAC6 Inhibitor Ricolinostat In Preclinical Model 3/8/2017 6:45:30 AM
Regenacy Pharma Release: Pharma's HDAC1,2 Inhibitors Demonstrate Single-Agent And Synergistic Activity With Azacitidine (Vidaza) In Preclinical Models Of Acute Myeloid Leukemia 1/11/2017 11:59:46 AM
Boston's Acetylon Gets Taken Out By Celgene (CELG), Will Spin Out Startup Regenacy Pharma 12/5/2016 5:51:44 AM
//-->